We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advertisement

D3 Pharma and Encap Drug Delivery Continue Partnership

News   Jun 19, 2012

 
D3 Pharma and Encap Drug Delivery Continue Partnership
 
 
Advertisement
 

RELATED ARTICLES

mRNA COVID-19 Vaccine Is Well-Tolerated and Generates Immune Response

News

A Phase 1 trial of an investigational mRNA vaccine to prevent SARS-CoV-2 infection has shown that the vaccine is well-tolerated and generates a strong immune response in older adults.

READ MORE

Computer Model Finds the Right Balance for Parkinson's Medication

News

As Parkinson's disease progresses, more levodopa is required to treat it. Too much, however, can lead to uncontrollable, involuntary bodily movements. To better understand the underlying reasons behind these effects, researchers created a model of the interactions between levodopa, dopamine, and the brain.

READ MORE

Smart Cells Developed With Potential To Treat Illness at the Cellular Level

News

New research by an international team of chemists describes a new type of artificial cell that can communicate with other cells within the body--with potential applications in the field of smart pharmaceuticals.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE